Search Results:

Have any questions? 706-721-6582 or [email protected]

Study Name	Principal Investigator
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study with an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis	Rivner, Michael
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients with generalized Myasthenia Gravis (gMG), followed by an open label extension phase	Barnes, Benjamin
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies	Rivner, Michael

RESEARCH. INNOVATION. DISCOVERY.

立即博